Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2016

View Archived Issues

New drug for GI radiation injury

ABLS II completes drug candidate feasibility program

CD31 expression on CD4 T cells correlated with respiratory disease in premature infants

P2Y6 receptor identified as a therapeutic target for asthma

Monoclonal antibody targets gastric inhibitory polypeptide to treat obesity

Acad10 gene knockout mice are a potential model of diabetes

Lundbeck patents BACE1 inhibitors

Bristol-Myers Squibb divulges IDO inhibitors to treat cancer

Lysosomal Therapeutics announces glucosylceramidase activators

Amorsa Therapeutics presents NMDA receptor antagonists

Eli Lilly introduces drug conjugates for bone disorders

Seed funding for Global Antibiotic Research and Development partnership

FDA will not meet PDUFA date for Sarepta's eteplirsen NDA

Eisai launches Fycompa tablets in Japan

Tetragenetics begins partnership with Theranyx

FDA grants fast track status to Novavax's RSV F vaccine

Alkermes begins phase I trial of ALKS-4230

Successful phase II results for solithromycin in community-acquired bacterial pneumonia

Kamada's alpha1-antitrypsin is available in Europe via myTomorrows early access platform

FDA advisory committee recommends approval of insulin glargine/lixisenatide

Juno Therapeutics signs intent to collaborate with Seattle Children's

SEATTLE study of emixustat in geographic atrophy fails to meet primary endpoint

BioXcel and Alnylam enter strategic collaboration to discover novel RNAi therapeutics

Michael J. Fox Foundation for Parkinson's Research announces new funding and partnership

FDA grants orphan drug designation to Viamet's VT-1598

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...